Aspect Biosystems
Latest round
- Series B
Last raised
- Jan 2025
Total raised
- $135M
Investors
- 8
About Aspect Biosystems
Founded in 2013 in Vancouver, Canada, Aspect Biosystems specializes in bioprinting technologies for regenerative medicine.Aspect Biosystems focuses on developing and commercializing bioprinting tissue therapeutics aimed at addressing unmet medical needs. Their proprietary AI-powered bioprinting platform combines computational tools, therapeutic cells, and biomaterials to create allogeneic tissues, which are utilized for repairing or supplementing biological functions in patients suffering from metabolic and endocrine diseases.Aspect Biosystems generates revenue through partnerships and collaborations with pharmaceutical and biotech companies, focusing on the development of bioprinted tissue therapeutics.00 mn, Aspect Biosystems is poised to enhance its research and development efforts for bioprinted tissue therapeutics. The company plans to expand its product offerings and enter new markets, leveraging this financial support to accelerate its initiatives in regenerative medicine.
Who invested in Aspect Biosystems
8 investors across 2 rounds
See all investors in Aspect Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aspect Biosystems
Who invested in Aspect Biosystems?
Aspect Biosystems has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aspect Biosystems raised?
Aspect Biosystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aspect Biosystems last raise money?
Aspect Biosystems's most recent round on record is a Series B, in Jan 2025.
What does Aspect Biosystems do?
Founded in 2013 in Vancouver, Canada, Aspect Biosystems specializes in bioprinting technologies for regenerative medicine.
Where is Aspect Biosystems headquartered?
Aspect Biosystems is headquartered in Vancouver, Canada.
Which VCs invest in companies like Aspect Biosystems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aspect Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aspect Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.